NATIONAL CONFERENCE (IPTCON-2018) ON INNOVATIVE RESEARCH TRENDS IN DRUG DISCOVERY at SRI PADMAVATI MAHILA VISVAVIDYALAYAM
About University
Sri Padmavati Mahila Visvavidyalayam, the only women's university for both the states of Andhra Pradesh and Telangana was established in 1983 by the then Chief Minister Sri. N.T. Rama Rao. The University is located in the temple town of Tirupati in a serene campus spread over 138.43 acres with all necessary infrastructure to run its academic programs. SPMVV has established itself as a center for research in emerging areas. It is accredited with A Grade by NAAC in 2016. Since its inception, with highly gualified teachers and well eguipped laboratories large number of women students are being trained in all aspects of life and are being well furnished to contribute to the social, political and moral development of the society.
The Indian Institute of Technology Kanpur was established in the year 1960. The Parliament of India passed the ‘Institutes of Technology Act 1961’ declaring all the IITs as “Institutions of National Importance”. The Parliamentary Act has given absolute autonomy to the IITs. When the foundation stone of the IIT system was laid, it was perceived that taking help from the industrially advanced western countries might be lot more effective in achieving the status of a world class technical institute. Hence, IIT Kanpur had a massive collaboration with USA through a specially created programme- KIAP (Kanpur Indo American Programme).
A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.
India's Council of Scientific and Industrial Research (CSIR) has a specialized service Unit for Research and Development of Information Products (URDIP) which is involved in the pre-research and pre-development phase of the research projects by providing intellectual property and techno-commercial information services. URDIP provides value added information services to wide array of clients including start-up companies, SMEs, Research Institutes within and outside CSIR, large Indian Corporate and Multinational Corporations. It’s primary clients include R&D, legal, new business development and mutifunctional corporate teams.
The United States Pharmacopeia (USP) is a non–governmental, official public standards–setting authority for prescription and over–the–counter medicines and other healthcare products manufactured or sold in the United States. USP also sets widely recognized standards for food ingredients and dietary supplements. USP sets standards for the quality, purity, strength, and consistency of these products–critical to the public health. USP's standards are recognized and used in more than 130 countries around the globe. These standards have helped to ensure public health throughout the world for close to 200 years.
The Mumbai University Institute of Chemical Technology, known earlier as UDCT is the most outstanding Institute of the University of Mumbai. This prestigious institute is a jewel in the crown of the University of Mumbai. It was founded on 4th August 1934 and was recently awarded the status of the Institute on 26th January 2002 and renamed MUICT. It enjoys a unique and prominent place amongst the premier institutes that are engaged in education, training and research in the field of Chemical Engineering, Chemical Technology and Pharmacy in India. Located in central Mumbai over a lush green campus of 16 acres, the MUICT has a built-up area of 33000 m2 including classrooms, laboratories and hostels.
Covance, a $15 billion Fortune 500 company, with operations in over 97 countries, has led the way in improving patient outcomes through visionary data sciences over the last five decades. We have supported 100% of the top 50 drugs in the market and all the oncology medicines approved in 2016. Our team of over 57,000 across the globe is committed to advancing healthcare and bringing new medicines to market sooner. Our unique perspectives, built from decades of scientific expertise and precision delivery, help our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Driven by a passion for excellence and a relentless commitment to quality, we unlock opportunities that advance innovation and deliver the promise of a healthier world. Together, with our large pharmaceutical and emerging biotech clients, Covance transforms today's health care challenges into tomorrow's solutions.
